About Fleming Fund:
The Fleming Fund is a global £265m UK aid programme building global partnerships. It aims to:
** Improve AMR (Anti-Microbial Resistance) surveillance
** Share the best of UK and international expertise to strengthen national public health capabilities in surveillance.
** Enable countries to improve the collection and use of AMR data in line with their National Action Plans to
inform policy and delivery of healthcare. In Pakistan, it kicked off at Pakistan’s National Institute for Health in September 2019. The Fleming Fund is a £265 million UK aid investment to tackle antimicrobial resistance in low- and middle-income countries around the world led by Mott MacDonald. The Pakistan country programme is managed by DAI-Pakistan in collaboration with its consortium partners Indus Hospital & Health Network , Health Security Partners and Liverpool School of Tropical Medicine , to support government of Pakistan in curtailing AMR holistically. 🐔 🌍🌱 👨👩👧 💧
